Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 13.60
+0.60 (4.62%)
At close: Feb 26, 2026
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €231.42 million as of February 26, 2026. Its market cap has increased by 38.49% in one year.
Market Cap
231.42M
Enterprise Value
235.05M
Revenue
240.68M
Ranking
n/a
PE Ratio
16.00
Stock Price
€13.60
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 231.42M, an increase of 2,982.97%. That is a compound annual growth rate of 13.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 221.21M | -1.52% |
| Dec 31, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.66B |
| Laboratorios Farmaceuticos Rovi | 3.99B |
| Almirall | 2.71B |
| Faes Farma | 1.55B |
| Pharma Mar | 1.35B |
| Clínica Baviera | 839.03M |
| Oryzon Genomics | 246.02M |
| Atrys Health | 235.21M |